Genetics Generation Advancement Corp. (TPEX:4160)

Market Cap	1.30B
Revenue (ttm)	638.35M
Net Income (ttm)	48.13M
Shares Out	26.69M
EPS (ttm)	1.80
PE Ratio	27.02
Forward PE	n/a
Dividend	1.85 (3.71%)
Ex-Dividend Date	Sep 19, 2024

Volume	25,558
Average Volume	24,370
Open	48.70
Previous Close	48.65
Day's Range	48.50 - 49.80
52-Week Range	46.90 - 150.87
Beta	0.29
RSI	44.36
Earnings Date	Aug 11, 2025

About TPEX:4160

Genetics Generation Advancement Corp. provides genetic testing and informatics services in Taiwan. The company offers testing services, including pre-implantation, prenatal, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology testing, and neonatology and pediatrics testing, as well as gastroenterology, hepatology, oncology, and medical research services. It also provides life sciences, materials sciences, research and development management, enterprise quality management, process production o...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 104
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4160

Financial Performance

In 2024, TPEX:4160's revenue was 661.86 million, an increase of 11.71% compared to the previous year's 592.50 million. Earnings were 54.70 million, an increase of 91.49%.